Tempus AI (TEM) may be building one of healthcare's fastest-growing artificial intelligence (AI) platforms, but the stock ...

UPPSALA, SE / ACCESS Newswire / June 30, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, ...

We just covered the 10 Stocks That Will 10X According to Social Media. Tempus AI (NASDAQ:TEM) ranks #7 (see 5 Stocks That ...

In the first nine months of 2025, Tempus AI Inc. TEM achieved several key regulatory milestones that strengthened its position in AI-driven diagnostics. In September 2025, the company received FDA 510 ...

Tempus AI TEM is slowly becoming one of the most vertically integrated data and diagnostics platforms in healthcare, bringing together genomics, multimodal real-world data and clinical AI into a ...

Investors with a lot of money to spend have taken a bullish stance on Tempus AI (NASDAQ:TEM). And retail traders should know. We noticed this today when the trades showed up on publicly available ...

Tempus reported core business revenue growth of more than 33% including Ambry, reinforcing investor confidence in the scale of its platform. Executives guided to $1.59 billion in 2026 revenue and ...

Artificial Intelligence (AI)-based healthcare solutions company Tempus AI TEM has continued to capture investors’ attention despite reporting weaker-than-expected fourth-quarter 2024 results on Feb.

Deep-pocketed investors have adopted a bearish approach towards Tempus AI (NASDAQ:TEM), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced publication of successful multi-site validation ...